Open access
Aug 2026
Real‐World Validation of the Clinical Distinctiveness of IDH‐Mutant Glioblastoma in the SEER Transition Era: A Population‐Based Study Integrating Machine Learning
This study aims to provide real‐world validation of this reclassification using the specific ICD‐O‐3 code (9445/3) from the Surveillance, Epidemiology, and End Results (SEER) “Transition Era” (2018–2022) and develop a machine learning (ML)‐based prognostic model.
De-Wei Du, Amu Jike, Dongnan Yu et al.
· Brain and Behavior · 0 citations